Integrating Ultrahigh‐Performance Liquid Chromatography–Mass Spectrometry and Network Pharmacology: Systematic Identification and Quantification of Bioactive Components in Erdong–Yangxin Oral Liquid, An Antidepressant Herbal Formulation
Journal of Separation Science · 2025
DOI: 10.1002/jssc.70342 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Separation Science, 2025. Verfasst von Mei Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Science and Technology Experimental Center, Shanghai University of Traditional Chinese Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Drugs, Chinese Herbal, Network Pharmacology, Antidepressive Agents. Die Arbeit nennt 38 Literaturangaben.
Abstract (Originalsprache)
Erdong–Yangxin oral liquid (EYOL) is a traditional Chinese medicine (TCM) prescription that demonstrates clinical efficacy in treating depression, yet its comprehensive chemical profile and quality‐control markers remain insufficiently studied. This study aimed to systematically characterize its chemical composition and establish a robust method for quality assessment. First, ultrahigh‐performance liquid chromatography (UHPLC)–linear ion trap quadrupole–Orbitrap mass spectrometry enabled the tentative identification of 149 compounds, primarily iridoid glycosides, flavonoids, and saponins. Subsequently, network pharmacology analysis predicted several components, such as dioscin, calycosin, and ruscogenin, as potential bioactive candidates based on their target network associations. To quantitatively assess key constituents, a novel method based on UHPLC–tandem mass spectrometry was established and fully validated for 15 components selected by integrating network pharmacology predictions, phytochemical characteristics, and pharmacopoeia references. Quantitative results revealed catalpol as the predominant component, followed by rehmannioside D, lobetyolin, dioscin, and calycosin‐7‐ O ‐β‐ d ‐glucoside. The study establishes a comprehensive chemical basis for EYOL and a reliable quantitative approach for its quality control, facilitating further research into its pharmacodynamic material basis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Science and Technology Experimental Center, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
- Institute of Mental Disorders of Traditional Chinese Medicine, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Shanghai Key Laboratory of Gene Editing and Cell Therapy for Rare Diseases, Shanghai, China.
- Department of Pharmacy, Eye & ENT Hospital, Fudan University, Shanghai, China.
Zitieren
APA
Wang, M., Zhang, J., Zhang, H., Li, J., Gu, J., & Shi, R. (2025). Integrating Ultrahigh‐Performance Liquid Chromatography–Mass Spectrometry and Network Pharmacology: Systematic Identification and Quantification of Bioactive Components in Erdong–Yangxin Oral Liquid, An Antidepressant Herbal Formulation. Journal of Separation Science. https://doi.org/10.1002/jssc.70342
Vancouver
Wang M, Zhang J, Zhang H, Li J, Gu J, Shi R. Integrating Ultrahigh‐Performance Liquid Chromatography–Mass Spectrometry and Network Pharmacology: Systematic Identification and Quantification of Bioactive Components in Erdong–Yangxin Oral Liquid, An Antidepressant Herbal Formulation. Journal of Separation Science. 2025. doi:10.1002/jssc.70342
BibTeX
@article{Wang2025,
author = {Wang, Mei and Zhang, Jianming and Zhang, Huishan and Li, Jiaxuan and Gu, Jifeng and Shi, Rong},
title = {Integrating Ultrahigh‐Performance Liquid Chromatography–Mass Spectrometry and Network Pharmacology: Systematic Identification and Quantification of Bioactive Components in Erdong–Yangxin Oral Liquid, An Antidepressant Herbal Formulation},
journal = {Journal of Separation Science},
year = {2025},
doi = {10.1002/jssc.70342}
}
EUVIMED